An article just published in the August 2023 issue of The Lancet Oncology can be expected to create considerable discussion. This is the first randomized trial ever conducted where the clinical safety of an AI-supported mammography screen-reading protocol used by a single radiologist was compared with interpretations of mammography studies performed by two radiologists. Between April 2021 and July 2022, more than 80,000 women were randomly assigned to AI-supported interpretations performed by a single radiologist versus two radiologists' double reading without AI. In the study, the AI-supported screening model and the traditional double read radiologist approach each performed interpretations of studies for approximately 40,000 participants. According to the The Guardian newspaper, "[i]n total, 244 women (28%) recalled from AI-supported screening were found to have cancer compared with 203 women (25%) recalled from standard screening.

Source: The Guardian August 08, 2023 20:22 UTC